This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
TheStreet Open House

Regulus Therapeutics Inc
RGLS : NASDAQ : Health Care
$7.36 -0.19 | -2.52%
Today's Range: 7.31 - 7.40
Avg. Daily Volume: 66,400
09/16/14 - 11:39 AM ET

PEER GROUP: Biotechnology



Ticker Company Name Recent
Price($)
Market
Cap($M)
Price/
Earnings
Net Sales
TTM($M)
Net Income
TTM($M)
RGLS REGULUS THERAPEUTICS INC 8.03 348.44 n/m 13.94 -0.75
GERN GERON CORP 2.49 390.64 n/m 1.22 -44.56
TGTX TG THERAPEUTICS INC 9.94 378.92 n/m 0.15 60.00
PGNX PROGENICS PHARMACEUTICAL INC 5.42 376.99 n/m 7.13 -49.20
DVAX DYNAVAX TECHNOLOGIES CORP 1.43 375.92 n/m 12.32 21.29
EXEL EXELIXIS INC 1.91 372.66 n/m 21.28 -50.11
RTRX RETROPHIN INC 12.96 345.80 n/m 5.77 n/a
ZIOP ZIOPHARM ONCOLOGY INC 3.20 322.38 n/m 0.80 0.00
CUR NEURALSTEM INC 3.69 320.43 n/m 0.01 -94.99
RNA PROSENSA HOLDING NV 8.82 318.37 n/m 28.16 954.21
IMMU IMMUNOMEDICS INC 3.29 306.35 n/m 9.04 82.22
The peer group comparison is based on Major Biotechnology companies of comparable size.

Price Earnings Comparison

RGLS Ind Avg S&P 500
n/m 86.69 19.81
 

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV

Latest Stock Upgrades/Downgrades

Brokerage Partners


Top Rated Stocks Top Rated Funds Top Rated ETFs